Editorial How to improve diversity and equity in clinical trials through telemedicine?
##plugins.themes.bootstrap3.article.main##
Abstract
Dementia research is diverse, but sparse or non-existent in some regions of the world. According to Clinicaltrials.gov, 78.8% of all clinical trials were developed in Europe (51.4%) and the United States (27.4%). Only 14% were carried in Asia, 4.5% in Latin America, and 2% in Africa. There are large cultural, educational, ethnic, and socioeconomic differences between the world´s populations in different regions. Results obtained in one location are often not generalisable to all regions. Clinical research need to increase diversity and improve inclusion.
Downloads
Download data is not yet available.
##plugins.themes.bootstrap3.article.details##
How to Cite
Allegri, R. F., Roman, F., & Barceló, E. (2024). Editorial How to improve diversity and equity in clinical trials through telemedicine?. Journal of Applied Cognitive Neuroscience, 5(2), e6220. https://doi.org/10.17981/ JACN.5.2.2024.6220
Section
Editorial
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- NoDerivatives — If you remix, transform, or build upon the material, you may not distribute the modified material.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.